HMGN (Hemagen Diagnostics) OCF Yield %: -897.50 (As of Jun. 24, 2026)


What is Hemagen Diagnostics OCF Yield %?

Hemagen Diagnostics HMGN +766.67% OCF Yield % is -897.50 as of Jun. 24, 2026.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Hemagen Diagnostics's Trailing 12-Month Cash Flow from Operations is $-0.36 Mil, and Market Cap is $0.04 Mil. Therefore, Hemagen Diagnostics's OCF Yield % for today is -897.50%.

The historical rank and industry rank for Hemagen Diagnostics's OCF Yield % or its related term are showing as below:

HMGN' s OCF Yield % Range Over the Past 10 Years
Min: -17950   Med: 0   Max: -897.5
Current: -897.5

During the past 13 years, the highest OCF Yield % of Hemagen Diagnostics was -897.50%. The lowest was -17950.00%. And the median was %.

HMGN's OCF Yield % is not ranked
in the Biotechnology industry.
Industry Median: -8.55 vs HMGN: -897.50

Hemagen Diagnostics's OCF Margin % for the quarter that ended in Sep. 2012 was %.

Hemagen Diagnostics OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Hemagen Diagnostics OCF Yield % Related Terms

Hemagen Diagnostics OCF Yield % Historical Data

* Premium members only.

The historical data trend for Hemagen Diagnostics's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hemagen Diagnostics OCF Yield % Chart

Hemagen Diagnostics Annual Data
Trend Sep03 Sep04 Sep05 Sep06 Sep07 Sep08 Sep09 Sep10 Sep11 Sep12
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.50 1.39 -19.60 -72.08 -65.75

Hemagen Diagnostics Quarterly Data
Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55.61 -255.77 -100.03 10.90 -37.36

HMGN vs OBMP, NSPX, ATRX: OCF Yield % Comparison

For the Biotechnology subindustry, Hemagen Diagnostics's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hemagen Diagnostics OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hemagen Diagnostics's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Hemagen Diagnostics's OCF Yield % falls into.


Hemagen Diagnostics OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Hemagen Diagnostics's OCF Yield % for the fiscal year that ended in Sep. 2012 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-0.359 / 0.546
=-65.75%

Hemagen Diagnostics's annualized OCF Yield % for the quarter that ended in Sep. 2012 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-0.051 * 4 / 0.546
=-37.36%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -897.50 mean?
Hemagen Diagnostics (HMGN) has a OCF Yield % of -897.50 as of Jun. 24, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Hemagen Diagnostics and its competitors.
Is Hemagen Diagnostics' OCF Yield % too high?
Hemagen Diagnostics' current OCF Yield % is -897.50.
How does Hemagen Diagnostics' OCF Yield % compare to OBMP and NSPX?
Hemagen Diagnostics' OCF Yield % of -897.50 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Hemagen Diagnostics and its competitors. Hemagen Diagnostics's current OCF Yield % is -897.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemagen Diagnostics stock overvalued right now?
Hemagen Diagnostics (HMGN) has a current OCF Yield % of -897.50. The current OCF Yield % is -897.50. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Hemagen Diagnostics (HMGN), the current OCF Yield % is -897.50 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hemagen Diagnostics Business Description

Address 9033 Red Branch Road, Columbia, MD, USA, 21045
Hemagen Diagnostics Inc is a biotechnology company. It develops, manufactures and markets Food and Drug Administration cleared proprietary medical diagnostic test kits and components. The company's Virgo line of Immunoassays are used to aid in the diagnosis of autoimmune and infectious diseases and acute-phase proteins. The assays utilize multiple technologies including ELISA, immunofluorescence (IFA) and hemagglutination (HA). Its products include ANA Screen ELISA 96 Test System, Rubella IgG ELISA 96 Test System, AMA IFA 48 Test System and others.